European Markets for Orthopedic Biomaterials 2007

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Market Forecast
• 1.3 Competitive Analysis

2.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 2.1 Market Overview
• 2.2 Osteoarthritis Overview
  • 2.2.1 Causal Factors
  • 2.2.2 Treatment Alternatives to Hyaluronic Acid Viscosupplementation
• 2.3 Hyaluronic Acid Viscosupplementation Overview
• 2.4 Market Analysis
  • 2.4.1 Procedures
    • 2.4.1.1 Austrian HA Viscosupplementation Procedures
    • 2.4.1.2 French HA Viscosupplementation Procedures
    • 2.4.1.3 German HA Viscosupplementation Procedures
    • 2.4.1.4 Italian HA Viscosupplementation Procedures
    • 2.4.1.5 Spanish HA Viscosupplementation Procedures
    • 2.4.1.6 UK HA Viscosupplementation Procedures
  • 2.4.2 Market Forecast
    • 2.4.2.1 Austrian HA Viscosupplementation Market Forecast
    • 2.4.2.2 French HA Viscosupplementation Market Forecast
    • 2.4.2.3 German HA Viscosupplementation Market Forecast
    • 2.4.2.4 Italian HA Viscosupplementation Market Forecast
    • 2.4.2.5 Spanish HA Viscosupplementation Market Forecast
    • 2.4.2.6 UK HA Viscosupplementation Market Forecast
  • 2.4.3 Market Drivers and Limiters
    • 2.4.3.1 Market Drivers
    • 2.4.3.2 Market Limiters
• 2.5 Competitive Analysis

3.0 BONE GRAFT SUBSTITUTE MARKET

• 3.1 Market Overview
• 3.2 Bone Graft Substitute Overview
  • 3.2.1 Autograft
  • 3.2.2 Allograft
  • 3.2.3 Xenograft
  • 3.2.4 Demineralized Bone Matrix
  • 3.2.5 Synthetic Bone
  • 3.2.6 Growth Factors
• 3.3 Market Analysis
  • 3.3.1 Procedures
    • 3.3.1.1 Segmented by Material
    • 3.3.1.2 Segmented by Indication
    • 3.3.1.3 French Bone Graft Procedures
    • 3.3.1.4 German Bone Graft Procedures
    • 3.3.1.5 Italian Bone Graft Procedures
    • 3.3.1.6 Spanish Bone Graft Procedures
    • 3.3.1.7 UK Bone Graft Procedures
  • 3.3.2 Market Forecast
    • 3.3.2.1 French Bone Graft Substitute Market Forecast
    • 3.3.2.2 German Bone Graft Substitute Market Forecast
    • 3.3.2.3 Italian Bone Graft Substitute Market Forecast
    • 3.3.2.4 Spanish Bone Graft Substitute Market Forecast
    • 3.3.2.5 UK Bone Graft Substitute Market Forecast
  • 3.3.3 Market Drivers and Limiters
    • 3.3.3.1 Market Drivers
    • 3.3.3.2 Market Limiters
• 3.4 Competitive Analysis

4.0 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• 4.1 Market Overview
• 4.2 Autologous Chondrocyte Implantation Overview
  • 4.2.1 Osteoarticular Autografts
  • 4.2.2 Osteoarticular Allografts
  • 4.2.3 Autologous Chondrocyte Implantation
• 4.3 Market Analysis
  • 4.3.1 Procedures
  • 4.3.2 Market Forecast
    • 4.3.2.1 Austrian Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.2 French Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.3 German Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.4 Italian Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.5 Spanish Autologous Chondrocyte Implantation Market Forecast
    • 4.3.2.6 UK Autologous Chondrocyte Implantation Market Forecast
  • 4.3.3 Market Drivers and Limiters
    • 4.3.3.1 Market Drivers
    • 4.3.3.2 Market Limiters
• 4.4 Competitive Analysis

5.0 PLATELET CONCENTRATION SYSTEMS MARKET

• 5.1 Market Overview
• 5.2 Platelet Concentration Systems Overview
• 5.3 Market Analysis
  • 5.3.1 Market Forecast
  • 5.3.2 Market Drivers and Limiters
    • 5.3.2.1 Market Drivers
    • 5.3.2.2 Market Limiters
• 5.4 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit ES-1: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011
• Exhibit ES-2: 1-Injection HA Viscosupplementation Treatments, Europe, 2005-2011
• Exhibit ES-3: BGS Market, by Country, Europe (US$), 2005-2011
• Exhibit ES-4: ACI Market, Italy (US$), 2005-2011
• Exhibit ES-5: PCS Market, Europe (US$), 2005-2011
• Exhibit ES-6: Leading Competitors of the European Orthopedic Biomaterial Market, 2006

METHODOLOGY

• Exhibit M-1: Currency Exchange Rates, 2006

CHAPTER 1: EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET

• Exhibit 1-1: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 1-2: Orthopedic Biomaterials Market, by Segment, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 1-3: Orthopedic Biomaterials, Europe (€), 2005-2011
• Exhibit 1-4: Leading Competitors in the Orthopedic Biomaterials Market, by Segment, Europe, 2006
• Exhibit 1-5: Leading Competitors of the European Orthopedic Biomaterials Market, 2006

CHAPTER 2: HYALURONIC ACID VISCOSUPPLEMENTATION

• Exhibit 2-1: HA Viscosupplementation Market, Europe (US$), 2005-2011
• Exhibit 2-2: HA Viscosupplementation Injections and Treatments, Europe, 2006
• Exhibit 2-3: HA Viscosupplementation Injections and Treatments, Europe, 2005-2011
• Exhibit 2-4: HA Viscosupplementation Injections, by Country, Europe, 2005-2011
• Exhibit 2-5: HA Viscosupplementation Injections and Treatments, Austria, 2006
• Exhibit 2-6: HA Viscosupplementation Injections and Treatments, Austria, 2005-2011
• Exhibit 2-7: HA Viscosupplementation Injections and Treatments, France, 2006
• Exhibit 2-8: HA Viscosupplementation Injections andTreatments, France, 2005-2011
• Exhibit 2-9: HA Viscosupplementation Injections and Treatments, Germany, 2006
• Exhibit 2-10: HA Viscosupplementation Injections and Treatments, Germany, 2005-2011
• Exhibit 2-11: HA Viscosupplementation Injections and Treatments, Italy, 2006
• Exhibit 2-12: HA Viscosupplementation Injections and Treatments, Italy, 2005-2011
• Exhibit 2-13: HA Viscosupplementation Injections and Treatments, Spain, 2006
• Exhibit 2-14: HA Viscosupplementation Injections and Treatments, Spain, 2005-2011
• Exhibit 2-15: HA Viscosupplementation Injections and Treatments, UK, 2006
• Exhibit 2-16: HA Viscosupplementation Injections and Treatments, UK, 2005-2011
• Exhibit 2-17: HA Viscosupplementation Injection Market, Europe (US$), 2005-2011
• Exhibit 2-18: HA Viscosupplementation Injection Market, Europe (€), 2005-2011
• Exhibit 2-19: HA Viscosupplementation Treatment Market, Europe (US$), 2005-2011
• Exhibit 2-20: HA Viscosupplementation Treatment Market, Europe (€), 2005-2011
• Exhibit 2-21: HA Viscosupplementation Market, by Country, Europe (US$), 2005-2011
• Exhibit 2-22: HA Viscosupplementation Market, by Country, Europe (€), 2005-2011
• Exhibit 2-23: HA Viscosupplementation Injection Market, Austria (US$), 2005-2011
• Exhibit 2-24: HA Viscosupplementation Injection Market, Austria (€), 2005-2011
• Exhibit 2-25: HA Viscosupplementation Treatment Market, Austria (US$), 2005-2011
• Exhibit 2-26: HA Viscosupplementation Treatment Market, Austria (€), 2005-2011
• Exhibit 2-27: HA Viscosupplementation Injection Market, France (US$), 2005-2011
• Exhibit 2-28: HA Viscosupplementation Injection Market, France (€), 2005-2011
• Exhibit 2-29: HA Viscosupplementation Treatment Market, France (US$), 2005-2011
• Exhibit 2-30: HA Viscosupplementation Treatment Market, France (€), 2005-2011
• Exhibit 2-31: HA Viscosupplementation Injection Market, Germany (US$), 2005-2011
• Exhibit 2-32: HA Viscosupplementation Injection Market, Germany (€), 2005-2011
• Exhibit 2-33: HA Viscosupplementation Treatment Market, Germany (US$), 2005-2011
• Exhibit 2-34: HA Viscosupplementation Treatment Market, Germany (€), 2005-2011
• Exhibit 2-35: HA Viscosupplementation Injection Market, Italy (US$), 2005-2011
• Exhibit 2-36: A Viscosupplementation Injection Market, Italy (€), 2005-2011
• Exhibit 2-37: HA Viscosupplementation Treatment Market, Italy (US$), 2005-2011
• Exhibit 2-38: HA Viscosupplementation Treatment Market, Italy (€), 2005-2011
• Exhibit 2-39: HA Viscosupplementation Injection Market, Spain (US$), 2005-2011
• Exhibit 2-40: HA Viscosupplementation Injection Market, Spain (€), 2005-2011
• Exhibit 2-41: HA Viscosupplementation Treatment Market, Spain (US$), 2005-2011
• Exhibit 2-42: HA Viscosupplementation Treatment Market, Spain (€), 2005-2011
• Exhibit 2-43: HA Viscosupplementation Injection Market, UK (US$), 2005-2011
• Exhibit 2-44: HA Viscosupplementation Injection Market, UK (€), 2005-2011
• Exhibit 2-45: HA Viscosupplementation Injection Market, UK (£), 2005-2011
• Exhibit 2-46: HA Viscosupplementation Treatment Market, UK (US$), 2005-2011
• Exhibit 2-47: HA Viscosupplementation Treatment Market, UK (€), 2005-2011
• Exhibit 2-48: HA Viscosupplementation Treatment Market, UK (£), 2005-2011
• Exhibit 2-49: Drivers and Limiters of the HA Viscosupplementation Market, Europe
• Exhibit 2-50: Leading Competitors in the HA Viscosupplementation Treatment Market, by Country, Europe, 2006

CHAPTER 3: BONE GRAFT SUBSTITUTE MARKET

• Exhibit 3-1: BGS Market, by Country, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 3-2: Characteristics of BGS Materials
• Exhibit 3-3: Advantages and Disadvantages of Various BGS Materials
• Exhibit 3-4: Selected Synthetic BGS Materials
• Exhibit 3-5: Bone Graft Procedures, by Material, Europe, 2005-2011
• Exhibit 3-6: BGS Procedures, by Material, Europe, 2005-2011
• Exhibit 3-7: Bone Graft Procedures, by Indication, Europe, 2005-2011
• Exhibit 3-8: BGS Procedures, by Indication, Europe, 2005-2011
• Exhibit 3-9: BGS Procedures, by Indication, As a % of Total, Europe, 2005-2011
• Exhibit 3-10: Quantity of Bone Graft Material Used, by Indication
• Exhibit 3-11: Bone Graft Procedures, by Material, France, 2005-2011
• Exhibit 3-12: BGS Procedures, by Material, France, 2005-2011
• Exhibit 3-13: Bone Graft Procedures, by Indication, France, 2005-2011
• Exhibit 3-14: BGS Procedures, by Indication, France, 2005-2011
• Exhibit 3-15: Bone Graft Procedures, by Material, Germany, 2005-2011
• Exhibit 3-16: BGS Procedures, by Material, Germany, 2005-2011
• Exhibit 3-17: Bone Graft Procedures, by Indication, Germany, 2005-2011
• Exhibit 3-18: BGS Procedures, by Indication, Germany, 2005-2011
• Exhibit 3-19: Bone Graft Procedures, by Material, Italy, 2005-2011
• Exhibit 3-20: BGS Procedures, by Material, Italy, 2005-2011
• Exhibit 3-21: Bone Graft Procedures, by Indication, Italy, 2005-2011
• Exhibit 3-22: BGS Procedures, by Indication, Italy, 2005-2011
• Exhibit 3-23: Bone Graft Procedures, by Material, Spain, 2005-2011
• Exhibit 3-24: BGS Procedures, by Material, Spain, 2005-2011
• Exhibit 3-25: Bone Graft Procedures, by Indication, Spain, 2005-2011
• Exhibit 3-26: BGS Procedures, by Indication, Spain, 2005-2011
• Exhibit 3-27: Bone Graft Procedures, by Material, UK, 2005-2011
• Exhibit 3-28: BGS Procedures, by Material, UK, 2005-2011
• Exhibit 3-29: Bone Graft Procedures, by Indication, UK, 2005-2011
• Exhibit 3-30: BGS Procedures, by Indication, UK, 2005-2011
• Exhibit 3-31: BGS Procedural ASPs, by Indication, Europe (US$), 2005-2011
• Exhibit 3-32: BGS Procedural ASPs, by Indication, Europe (€), 2005-2011
• Exhibit 3-33: BGS Market, Europe (US$), 2005-2011
• Exhibit 3-34: BGS Market, Europe (€), 2005-2011
• Exhibit 3-35: BGS Market, by Country, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 3-36: BGS Market, by Country, Europe (€), 2005-2011
• Exhibit 3-37: BGS Market, by Country, As a % of Total, Europe, 2005-2011
• Exhibit 3-38: BGS Market, by Material, Europe (US$), 2005-2011
• Exhibit 3-39: BGS Market, by Material, Europe (€), 2005-2011
• Exhibit 3-40: BGS Market, by Indication, Europe (US$), 2005-2011
• Exhibit 3-41: BGS Market, by Indication, Europe (€), 2005-2011
• Exhibit 3-42: BGS Market, by Indication, As a % of Total, Europe, 2005-2011
• Exhibit 3-43: BGS Procedural ASPs, by Indication, France (US$), 2005-2011
• Exhibit 3-44: BGS Procedural ASPs, by Indication, France (€), 2005-2011
• Exhibit 3-45: BGS Market, France (US$), 2005-2011
• Exhibit 3-46: BGS Market, France (€), 2005-2011
• Exhibit 3-47: BGS Market, by Material, France (US$), 2005-2011
• Exhibit 3-48: BGS Market, by Material, France (€), 2005-2011
• Exhibit 3-49: BGS Market, by Indication, France (US$), 2005-2011
• Exhibit 3-50: BGS Market, by Indication, France (€), 2005-2011
• Exhibit 3-51: BGS Procedural ASPs, by Indication, Germany (US$), 2005-2011
• Exhibit 3-52: BGS Procedural ASPs, by Indication, Germany (€), 2005-2011
• Exhibit 3-53: BGS Market, Germany (US$), 2005-2011
• Exhibit 3-54: BGS Market, Germany (€), 2005-2011
• Exhibit 3-55: BGS Market, by Material, Germany (US$), 2005-2011
• Exhibit 3-56: BGS Market, by Material, Germany (€), 2005-2011
• Exhibit 3-57: BGS Market, by Indication, Germany (US$), 2005-2011
• Exhibit 3-58: BGS Market, by Indication, Germany (€), 2005-2011
• Exhibit 3-59: BGS Procedural ASPs, by Indication, Italy (US$), 2005-2011
• Exhibit 3-60: BGS Procedural ASPs, by Indication, Italy (€), 2005-2011
• Exhibit 3-61: BGS Market, Italy (US$), 2005-2011
• Exhibit 3-62: BGS Market, Italy (€), 2005-2011
• Exhibit 3-63: BGS Market, by Material, Italy (US$), 2005-2011
• Exhibit 3-64: BGS Market, by Material, Italy (€), 2005-2011
• Exhibit 3-65: BGS Market, by Indication, Italy (US$), 2005-2011
• Exhibit 3-66: BGS Market, by Indication, Italy (€), 2005-2011
• Exhibit 3-67: BGS Procedural ASPs, by Indication, Spain (US$), 2005-2011
• Exhibit 3-68: BGS Procedural ASPs, by Indication, Spain (€), 2005-2011
• Exhibit 3-69: BGS Market, Spain (US$), 2005-2011
• Exhibit 3-70: BGS Market, Spain (€), 2005-2011
• Exhibit 3-71: BGS Market, by Material, Spain (US$), 2005-2011
• Exhibit 3-72: BGS Market, by Material, Spain (€), 2005-2011
• Exhibit 3-73: BGS Market, by Indication, Spain (US$), 2005-2011
• Exhibit 3-74: BGS Market, by Indication, Spain (€), 2005-2011
• Exhibit 3-75: BGS Procedural ASPs, by Indication, UK (US$), 2005-2011
• Exhibit 3-76: BGS Procedural ASPs, by Indication, UK (€), 2005-2011
• Exhibit 3-77: BGS Procedural ASPs, by Indication, UK (£), 2005-2011
• Exhibit 3-78: BGS Market, UK (US$), 2005-2011
• Exhibit 3-79: BGS Market, UK (€), 2005-2011
• Exhibit 3-80: BGS Market, UK (£), 2005-2011
• Exhibit 3-81: BGS Market, by Material, UK (US$), 2005-2011
• Exhibit 3-82: BGS Market, by Material, UK (€), 2005-2011
• Exhibit 3-83: BGS Market, by Material, UK (£), 2005-2011
• Exhibit 3-84: BGS Market, by Indication, UK (US$), 2005-2011
• Exhibit 3-85: BGS Market, by Indication, UK (€), 2005-2011
• Exhibit 3-86: BGS Market, by Indication, UK (£), 2005-2011
• Exhibit 3-87: Drivers and Limiters of the BGS Market, Europe
• Exhibit 3-88: Leading Competitors in the BGS Market, by Country, as a % of Total, Europe, 2006

CHAPTER 4: AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

• Exhibit 4-1: ACI Market, Europe (US$), 2005-2011 (Graphical Format)
• Exhibit 4-2: ACI Procedures, by Country, Europe, 2005-2011
• Exhibit 4-3: ACI Procedure, by Country, Europe, as a % of Total, 2005-2011
• Exhibit 4-4: ACI Market, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 4-5: ACI Market, Europe (€), 2005-2011
• Exhibit 4-6: ACI Market, by Country, Europe (US$), 2005-2011
• Exhibit 4-7: ACI Market, by Country, Europe (€), 2005-2011
• Exhibit 4-8: ACI Market, by Country, as a % of Total, Europe, 2005-2011
• Exhibit 4-9: ACI Market, Austria (US$), 2005-2011
• Exhibit 4-10: ACI Market, Austria (€), 2005-2011
• Exhibit 4-11: ACI Market, France (US$), 2005-2011
• Exhibit 4-12: ACI Market, France (€), 2005-2011
• Exhibit 4-13: ACI Market, Germany (US$), 2005-2011
• Exhibit 4-14: ACI Market, Germany (€), 2005-2011
• Exhibit 4-15: ACI Market, Italy (US$), 2005-2011
• Exhibit 4-16: ACI Market, Italy (€), 2005-2011
• Exhibit 4-17: ACI Market, Spain (US$), 2005-2011
• Exhibit 4-18: ACI Market, Spain (€), 2005-2011
• Exhibit 4-19: ACI Market, UK (US$), 2005-2011
• Exhibit 4-20: ACI Market, UK (€), 2005-2011
• Exhibit 4-21: ACI Market, UK (£), 2005-2011
• Exhibit 4-22: Drivers and Limiters of the ACI Market, Europe, 2006
• Exhibit 4-23: Leading Competitors in the ACI Market, as a % of Total, Europe, 2006

CHAPTER 5: PLATELET CONCENTRATION SYSTEMS MARKET

• Exhibit 5-1: PCS Market, Europe (US$), 2005-2011(Graphical Format)
• Exhibit 5-2: PCS Market, Europe (US$), 2005-2011 (Tabular Format)
• Exhibit 5-3: PCS Market, Europe (€), 2005-2011
• Exhibit 5-4: Drivers and Limiters of the PCS market, Europe
• Exhibit 5-5: Leading Competitors in the PCS Market, as a % of Total, Europe, 2006